Jessica Bruno-Raiz
Chief Tech/Sci/R&D Officer bei TREX WIND-DOWN, INC.
Profil
Jessica Bruno-Raiz is currently the VP-Clinical Operations & Program Management at Timber Pharmaceuticals, Inc. Prior to this, she worked as the Director-Clinical Operations at Ferring Pharmaceuticals, Inc. from 2018 to 2019 and at Champions Oncology, Inc. from 2017 to 2018.
Ms. Bruno-Raiz completed her undergraduate degree from Drew University in 1999 and her graduate degree from Boston University School of Medicine in 2001.
Aktive Positionen von Jessica Bruno-Raiz
| Unternehmen | Position | Beginn |
|---|---|---|
| TREX WIND-DOWN, INC. | Chief Tech/Sci/R&D Officer | 01.03.2022 |
Ehemalige bekannte Positionen von Jessica Bruno-Raiz
| Unternehmen | Position | Ende |
|---|---|---|
Ferring Pharmaceuticals, Inc.
 Ferring Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ferring Pharmaceuticals, Inc. develops and markets fertility and endocrinology products. Its products include Bravelle, Repronex, Novarel, Acthrel and Desmopressin Acetate. The company's products are used in treatment of osteoarthritis, prostate cancer, and other infertility related diseases. Ferring Pharmaceuticals was founded in 1951 and is headquartered in Parsippany, NJ. | Chief Tech/Sci/R&D Officer | 01.10.2019 |
| CHAMPIONS ONCOLOGY, INC. | Chief Tech/Sci/R&D Officer | 01.09.2018 |
Ausbildung von Jessica Bruno-Raiz
| Drew University | Undergraduate Degree |
| Boston University School of Medicine | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| CHAMPIONS ONCOLOGY, INC. | Health Technology |
| TREX WIND-DOWN, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Ferring Pharmaceuticals, Inc.
Ferring Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ferring Pharmaceuticals, Inc. develops and markets fertility and endocrinology products. Its products include Bravelle, Repronex, Novarel, Acthrel and Desmopressin Acetate. The company's products are used in treatment of osteoarthritis, prostate cancer, and other infertility related diseases. Ferring Pharmaceuticals was founded in 1951 and is headquartered in Parsippany, NJ. | Health Technology |
